Reports

Industry Research Reports

Global Peptide Synthesizer Market Outlook, In‑Depth Analysis & Forecast to 2031

Global Peptide Synthesizer Market Outlook, In‑Depth Analysis & Forecast to 2031

Industry: Machinery & Equipment

Published Date: 2025-09-11

Pages: 149 Pages

Report ld: 5043268

application for samples

Request Sample

Custom reports

Customized Report

  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected
  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected

Peptide Synthesizer Market Size(US$)

den_QYR1
cagr

CAGR 2025-2031

2.6%

marketSize

Market Size,2031

USD 91.7

Million

Market Snapshot

Market Size in 2025 (Value)
US$ 78.6 million
Market Forecast in 2031(Value)
US$ 91.7 million
CAGR
2.6%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

The global Peptide Synthesizer market is projected to grow from US$ 76.8 million in 2024 to US$ 91.7 million by 2031, at a CAGR of 2.6% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.

Peptide Synthesizer is an instrument used for peptide synthesis according to the principle of solid phase peptide synthesis. Peptides are used to prepare epitope-specific antibodies, map antibody epitopes and enzyme binding sites and to design novel enzymes, drugs and vaccines. Peptide synthesis is characterized as the formation of a peptide bond between two amino acids.

As the introduction of peptide synthesizer, the development of polypeptide therapeutic market is becoming faster and faster, which drives the development of peptide synthesizer industry in return.

Aapptec, PTI, PSI, CEM, Biotage and Shimadzu are the top six manufacturers of peptide synthesizers worldwide, with a combined market share of about 70 percent. North America is the largest consumption place, with a consumption market share nearly 54%. Following North America, Europe is the second largest consumption place with the consumption market share of 23%.

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Peptide Synthesizer market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.

Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.

MARKET SEGMENTATION

By Company

  • AAPPTec
  • PTI
  • PSI
  • CEM
  • Biotage
  • Shimadzu
  • Activotec
  • CS Bio
  • Intavis AG
  • Hainan JBPharm

Consumption by Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Segment by Type

  • Mcg~mg
  • Mg~g
  • G~kg
  • Above kg

Segment by Application

  • University Laboratory
  • Biopharmaceutical Company
  • Synthesis Services Company

biaoTi CHAPTER OUTLINE

marn_i1

Chapter 1: Defines the Peptide Synthesizer study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.

marn_i1

Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts

marn_i1

Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.

marn_i1

Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.

marn_i1

Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks

marn_i1

Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.

marn_i1

Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.

marn_i1

Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.

marn_i1

Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.

marn_i1

Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.

marn_i1

Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles

marn_i1

Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.

marn_i1

Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.

marn_i1

Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.

marn_i1

Chapter 15: Actionable conclusions and strategic recommendations.

WHY THIS REPORT

Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:

Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:

Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).

Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.

Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).

Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).

Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region
Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

den_ic6
Product mix optimization based on local practices
Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

den_ic6
Competitor tactics in fragmented vs. consolidated markets
Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

den_ic6
Full Research Coverage
Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

den_ic6
19 Years Industry Expertise
19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

den_ic6
24/7 Fast Report Delivery
24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

den_ic6
Localized Strategic Analysis
Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

den_ic6
den_biaoTiZhungShi

TABLE OF CONTENTS

muLu

1 Study Coverage

1.1 Introduction to Peptide Synthesizer: Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global Peptide Synthesizer Market Size by Type, 2020 VS 2024 VS 2031

1.2.2 Mcg~mg

1.2.3 Mg~g

1.2.4 G~kg

1.2.5 Above kg

1.3 Market Segmentation by Application

1.3.1 Global Peptide Synthesizer Market Size by Application, 2020 VS 2024 VS 2031

1.3.2 University Laboratory

1.3.3 Biopharmaceutical Company

1.3.4 Synthesis Services Company

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

muLu

2 Executive Summary

2.1 Global Peptide Synthesizer Revenue Estimates and Forecasts 2020-2031

2.2 Global Peptide Synthesizer Revenue by Region

2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031

2.2.2 Historical and Forecasted Revenue by Region (2020--2031)

2.2.3 Global Revenue Market Share by Region (2020-2031)

2.3 Global Peptide Synthesizer Sales Estimates and Forecasts 2020-2031

2.4 Global Peptide Synthesizer Sales by Region

2.4.1 Sales Comparison: 2020 VS 2024 VS 2031

2.4.2 Historical and Forecasted Sales by Region (2020-2031)

2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends

2.4.4 Global Sales Market Share by Region (2020-2031)

muLu

3 Global Production Analysis

3.1 Global Peptide Synthesizer Production Capacity and Utilization Rates (2020–2031)

3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)

3.3 Regional Production Dynamics

3.3.1 Historic Production by Region (2020-2025)

3.3.2 Forecasted Production by Region (2026-2031)

3.3.3 Production Market Share by Region (2020-2031)

3.3.4 Regulatory and Trade Policy Impact on Production

3.3.5 Production Capacity Enablers and Constraints

3.4 Key Regional Production Hubs

3.4.1 North America

3.4.2 Europe

3.4.3 China

3.4.4 Japan

muLu

4 Competition by Manufacturers

4.1 Global Peptide Synthesizer Sales by Manufacturers

4.1.1 Global Sales Volume by Manufacturers (2020-2025)

4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)

4.2 Global Peptide Synthesizer Manufacturer Revenue Rankings and Tiers

4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)

4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)

4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

4.3 Manufacturer Profitability Profiles and Pricing Strategies

4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)

4.3.2 Manufacturer-Level Price Trends (2020-2025)

4.4 Key Manufacturers Manufacturing Base and Headquarters

4.5 Main Product Type Market Size by Manufacturers

4.5.1 Mcg~mg Market Size by Manufacturers

4.5.2 Mg~g Market Size by Manufacturers

4.5.3 G~kg Market Size by Manufacturers

4.5.4 Above kg Market Size by Manufacturers

4.6 Global Peptide Synthesizer Market Concentration and Dynamics

4.6.1 Global Market Concentration (CR5 and HHI)

4.6.2 Entrant/Exit Impact Analysis

4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

muLu

5 Global Product Segmentation Analysis

5.1 Global Peptide Synthesizer Sales Performance by Type

5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)

5.1.2 Global Sales Market Share by Type (2020-2031)

5.2 Global Peptide Synthesizer Revenue Trends by Type

5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)

5.2.2 Global Revenue Market Share by Type (2020-2031)

5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)

5.4 Product Technology Differentiation

5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk

5.5.1 High-Growth Niches and Adoption Drivers

5.5.2 Profitability Hotspots and Cost Drivers

5.5.3 Substitution Threats

muLu

6 Global Downstream Application Analysis

6.1 Global Peptide Synthesizer Sales by Application

6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)

6.1.2 Global Sales Market Share by Application (2020-2031)

6.1.3 High-Growth Application Identification

6.1.4 Emerging Application Case Studies

6.2 Global Peptide Synthesizer Revenue by Application

6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)

6.2.2 Revenue Market Share by Application (2020-2031)

6.3 Global Pricing Dynamics by Application (2020-2031)

6.4 Downstream Customer Analysis

6.4.1 Top Customers by Region

6.4.2 Top Customers by Application

muLu

7 North America

7.1 North America Sales Volume and Revenue (2020-2031)

7.2 North America Key Manufacturers Sales Revenue in 2024

7.3 North America Peptide Synthesizer Sales and Revenue by Type (2020-2031)

7.4 North America Peptide Synthesizer Sales and Revenue by Application (2020-2031)

7.5 North America Growth Accelerators and Market Barriers

7.6 North America Peptide Synthesizer Market Size by Country

7.6.1 North America Revenue by Country

7.6.2 North America Sales Trends by Country

7.6.3 US

7.6.4 Canada

7.6.5 Mexico

muLu

8 Europe

8.1 Europe Sales Volume and Revenue (2020-2031)

8.2 Europe Key Manufacturers Sales Revenue in 2024

8.3 Europe Peptide Synthesizer Sales and Revenue by Type (2020-2031)

8.4 Europe Peptide Synthesizer Sales and Revenue by Application (2020-2031)

8.5 Europe Growth Accelerators and Market Barriers

8.6 Europe Peptide Synthesizer Market Size by Country

8.6.1 Europe Revenue by Country

8.6.2 Europe Sales Trends by Country

8.6.3 Germany

8.6.4 France

8.6.5 U.K.

8.6.6 Italy

8.6.7 Russia

muLu

9 Asia-Pacific

9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)

9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024

9.3 Asia-Pacific Peptide Synthesizer Sales and Revenue by Type (2020-2031)

9.4 Asia-Pacific Peptide Synthesizer Sales and Revenue by Application (2020-2031)

9.5 Asia-Pacific Peptide Synthesizer Market Size by Region

9.5.1 Asia-Pacific Revenue by Region

9.5.2 Asia-Pacific Sales Trends by Region

9.6 Asia-Pacific Growth Accelerators and Market Barriers

9.7 Southeast Asia

9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)

9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand

9.8 China

9.9 Japan

9.10 South Korea

9.11 China Taiwan

9.12 India

muLu

10 Central and South America

10.1 Central and South America Sales Volume and Revenue (2020-2031)

10.2 Central and South America Key Manufacturers Sales Revenue in 2024

10.3 Central and South America Peptide Synthesizer Sales and Revenue by Type (2020-2031)

10.4 Central and South America Peptide Synthesizer Sales and Revenue by Application (2020-2031)

10.5 Central and South America Investment Opportunities and Key Challenges

10.6 Central and South America Peptide Synthesizer Market Size by Country

10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)

10.6.2 Brazil

10.6.3 Argentina

muLu

11 Middle East and Africa

11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)

11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024

11.3 Middle East and Africa Peptide Synthesizer Sales and Revenue by Type (2020-2031)

11.4 Middle East and Africa Peptide Synthesizer Sales and Revenue by Application (2020-2031)

11.5 Middle East and Africa Investment Opportunities and Key Challenges

11.6 Middle East and Africa Peptide Synthesizer Market Size by Country

11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)

11.6.2 GCC Countries

11.6.3 Turkey

11.6.4 Egypt

11.6.5 South Africa

muLu

12 Corporate Profile

12.1 AAPPTec

12.1.1 AAPPTec Corporation Information

12.1.2 AAPPTec Business Overview

12.1.3 AAPPTec Peptide Synthesizer Product Models, Descriptions and Specifications

12.1.4 AAPPTec Peptide Synthesizer Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.1.5 AAPPTec Peptide Synthesizer Sales by Product in 2024

12.1.6 AAPPTec Peptide Synthesizer Sales by Application in 2024

12.1.7 AAPPTec Peptide Synthesizer Sales by Geographic Area in 2024

12.1.8 AAPPTec Peptide Synthesizer SWOT Analysis

12.1.9 AAPPTec Recent Developments

12.2 PTI

12.2.1 PTI Corporation Information

12.2.2 PTI Business Overview

12.2.3 PTI Peptide Synthesizer Product Models, Descriptions and Specifications

12.2.4 PTI Peptide Synthesizer Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.2.5 PTI Peptide Synthesizer Sales by Product in 2024

12.2.6 PTI Peptide Synthesizer Sales by Application in 2024

12.2.7 PTI Peptide Synthesizer Sales by Geographic Area in 2024

12.2.8 PTI Peptide Synthesizer SWOT Analysis

12.2.9 PTI Recent Developments

12.3 PSI

12.3.1 PSI Corporation Information

12.3.2 PSI Business Overview

12.3.3 PSI Peptide Synthesizer Product Models, Descriptions and Specifications

12.3.4 PSI Peptide Synthesizer Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.3.5 PSI Peptide Synthesizer Sales by Product in 2024

12.3.6 PSI Peptide Synthesizer Sales by Application in 2024

12.3.7 PSI Peptide Synthesizer Sales by Geographic Area in 2024

12.3.8 PSI Peptide Synthesizer SWOT Analysis

12.3.9 PSI Recent Developments

12.4 CEM

12.4.1 CEM Corporation Information

12.4.2 CEM Business Overview

12.4.3 CEM Peptide Synthesizer Product Models, Descriptions and Specifications

12.4.4 CEM Peptide Synthesizer Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.4.5 CEM Peptide Synthesizer Sales by Product in 2024

12.4.6 CEM Peptide Synthesizer Sales by Application in 2024

12.4.7 CEM Peptide Synthesizer Sales by Geographic Area in 2024

12.4.8 CEM Peptide Synthesizer SWOT Analysis

12.4.9 CEM Recent Developments

12.5 Biotage

12.5.1 Biotage Corporation Information

12.5.2 Biotage Business Overview

12.5.3 Biotage Peptide Synthesizer Product Models, Descriptions and Specifications

12.5.4 Biotage Peptide Synthesizer Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.5.5 Biotage Peptide Synthesizer Sales by Product in 2024

12.5.6 Biotage Peptide Synthesizer Sales by Application in 2024

12.5.7 Biotage Peptide Synthesizer Sales by Geographic Area in 2024

12.5.8 Biotage Peptide Synthesizer SWOT Analysis

12.5.9 Biotage Recent Developments

12.6 Shimadzu

12.6.1 Shimadzu Corporation Information

12.6.2 Shimadzu Business Overview

12.6.3 Shimadzu Peptide Synthesizer Product Models, Descriptions and Specifications

12.6.4 Shimadzu Peptide Synthesizer Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.6.5 Shimadzu Recent Developments

12.7 Activotec

12.7.1 Activotec Corporation Information

12.7.2 Activotec Business Overview

12.7.3 Activotec Peptide Synthesizer Product Models, Descriptions and Specifications

12.7.4 Activotec Peptide Synthesizer Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.7.5 Activotec Recent Developments

12.8 CS Bio

12.8.1 CS Bio Corporation Information

12.8.2 CS Bio Business Overview

12.8.3 CS Bio Peptide Synthesizer Product Models, Descriptions and Specifications

12.8.4 CS Bio Peptide Synthesizer Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.8.5 CS Bio Recent Developments

12.9 Intavis AG

12.9.1 Intavis AG Corporation Information

12.9.2 Intavis AG Business Overview

12.9.3 Intavis AG Peptide Synthesizer Product Models, Descriptions and Specifications

12.9.4 Intavis AG Peptide Synthesizer Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.9.5 Intavis AG Recent Developments

12.10 Hainan JBPharm

12.10.1 Hainan JBPharm Corporation Information

12.10.2 Hainan JBPharm Business Overview

12.10.3 Hainan JBPharm Peptide Synthesizer Product Models, Descriptions and Specifications

12.10.4 Hainan JBPharm Peptide Synthesizer Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.10.5 Hainan JBPharm Recent Developments

muLu

13 Value Chain and Supply-Chain Analysis

13.1 Peptide Synthesizer Industry Chain

13.2 Peptide Synthesizer Upstream Materials Analysis

13.2.1 Raw Materials

13.2.2 Key Suppliers Market Share & Risk Assessment

13.3 Peptide Synthesizer Integrated Production Analysis

13.3.1 Manufacturing Footprint Analysis

13.3.2 Production Technology Overview

13.3.3 Regional Cost Drivers

13.4 Peptide Synthesizer Sales Channels and Distribution Networks

13.4.1 Sales Channels

13.4.2 Distributors

muLu

14 Peptide Synthesizer Market Dynamics

14.1 Industry Trends and Evolution

14.2 Market Growth Drivers and Emerging Opportunities

14.3 Market Challenges, Risks, and Restraints

muLu

15 Key Findings in the Global Peptide Synthesizer Study

muLu

16 Appendix

16.1 Research Methodology

16.1.1 Methodology/Research Approach

16.1.1.1 Research Programs/Design

16.1.1.2 Market Size Estimation

16.1.1.3 Market Breakdown and Data Triangulation

16.1.2 Data Source

16.1.2.1 Secondary Sources

16.1.2.2 Primary Sources

16.2 Author Details

den_biaoTiZhungShi

TABLE OF FIGURES

muLu

List of Tables

Table 1. Global Peptide Synthesizer Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Peptide Synthesizer Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Peptide Synthesizer Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Peptide Synthesizer Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Peptide Synthesizer Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Peptide Synthesizer Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Units)
Table 7. Global Peptide Synthesizer Sales by Region (2020-2025) & (Units)
Table 8. Global Peptide Synthesizer Sales by Region (2026-2031) & (Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Peptide Synthesizer Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Units)
Table 11. Global Peptide Synthesizer Production by Region (2020-2025) & (Units)
Table 12. Global Peptide Synthesizer Production by Region (2026-2031) & (Units)
Table 13. Global Peptide Synthesizer Sales by Manufacturers (2020-2025) & (Units)
Table 14. Global Peptide Synthesizer Sales Share by Manufacturers (2020-2025)
Table 15. Global Peptide Synthesizer Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 16. Global Peptide Synthesizer Revenue Market Share by Manufacturers (2020-2025)
Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 18. Global Peptide Synthesizer by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide Synthesizer as of 2024)
Table 19. Global Peptide Synthesizer Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 20. Global Peptide Synthesizer Average Selling Price (ASP) by Manufacturers (2020-2025) & (K USD/Unit)
Table 21. Key Manufacturers Peptide Synthesizer Manufacturing Base and Headquarters
Table 22. Global Peptide Synthesizer Market Concentration Ratio (CR5 and HHI)
Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 25. Global Peptide Synthesizer Sales by Type (2020-2025) & (Units)
Table 26. Global Peptide Synthesizer Sales by Type (2026-2031) & (Units)
Table 27. Global Peptide Synthesizer Revenue by Type (2020-2025) & (US$ Million)
Table 28. Global Peptide Synthesizer Revenue by Type (2026-2031) & (US$ Million)
Table 29. Global Peptide Synthesizer ASP by Type (2020-2031) & (K USD/Unit)
Table 30. Technical Specifications by Key Product Type
Table 31. Global Peptide Synthesizer Sales by Application (2020-2025) & (Units)
Table 32. Global Peptide Synthesizer Sales by Application (2026-2031) & (Units)
Table 33. Peptide Synthesizer High-Growth Sectors Demand CAGR (2024-2031)
Table 34. Global Peptide Synthesizer Revenue by Application (2020-2025) & (US$ Million)
Table 35. Global Peptide Synthesizer Revenue by Application (2026-2031) & (US$ Million)
Table 36. Global Peptide Synthesizer ASP by Application (2020-2031) & (K USD/Unit)
Table 37. Top Customers by Region
Table 38. Top Customers by Application
Table 39. North America Peptide Synthesizer Growth Accelerators and Market Barriers
Table 40. North America Peptide Synthesizer Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 41. North America Peptide Synthesizer Sales (Units) by Country (2020 VS 2024 VS 2031)
Table 42. Europe Peptide Synthesizer Growth Accelerators and Market Barriers
Table 43. Europe Peptide Synthesizer Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 44. Europe Peptide Synthesizer Sales (Units) by Country (2020 VS 2024 VS 2031)
Table 45. Asia-Pacific Peptide Synthesizer Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Asia-Pacific Peptide Synthesizer Sales (Units) by Country (2020 VS 2024 VS 2031)
Table 47. Asia-Pacific Peptide Synthesizer Growth Accelerators and Market Barriers
Table 48. Southeast Asia Peptide Synthesizer Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 49. Central and South America Peptide Synthesizer Investment Opportunities and Key Challenges
Table 50. Central and South America Peptide Synthesizer Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 51. Middle East and Africa Peptide Synthesizer Investment Opportunities and Key Challenges
Table 52. Middle East and Africa Peptide Synthesizer Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 53. AAPPTec Corporation Information
Table 54. AAPPTec Description and Major Businesses
Table 55. AAPPTec Product Models, Descriptions and Specifications
Table 56. AAPPTec Capacity, Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2020-2025)
Table 57. AAPPTec Sales Value Proportion by Product in 2024
Table 58. AAPPTec Sales Value Proportion by Application in 2024
Table 59. AAPPTec Sales Value Proportion by Geographic Area in 2024
Table 60. AAPPTec Peptide Synthesizer SWOT Analysis
Table 61. AAPPTec Recent Developments
Table 62. PTI Corporation Information
Table 63. PTI Description and Major Businesses
Table 64. PTI Product Models, Descriptions and Specifications
Table 65. PTI Capacity, Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2020-2025)
Table 66. PTI Sales Value Proportion by Product in 2024
Table 67. PTI Sales Value Proportion by Application in 2024
Table 68. PTI Sales Value Proportion by Geographic Area in 2024
Table 69. PTI Peptide Synthesizer SWOT Analysis
Table 70. PTI Recent Developments
Table 71. PSI Corporation Information
Table 72. PSI Description and Major Businesses
Table 73. PSI Product Models, Descriptions and Specifications
Table 74. PSI Capacity, Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2020-2025)
Table 75. PSI Sales Value Proportion by Product in 2024
Table 76. PSI Sales Value Proportion by Application in 2024
Table 77. PSI Sales Value Proportion by Geographic Area in 2024
Table 78. PSI Peptide Synthesizer SWOT Analysis
Table 79. PSI Recent Developments
Table 80. CEM Corporation Information
Table 81. CEM Description and Major Businesses
Table 82. CEM Product Models, Descriptions and Specifications
Table 83. CEM Capacity, Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2020-2025)
Table 84. CEM Sales Value Proportion by Product in 2024
Table 85. CEM Sales Value Proportion by Application in 2024
Table 86. CEM Sales Value Proportion by Geographic Area in 2024
Table 87. CEM Peptide Synthesizer SWOT Analysis
Table 88. CEM Recent Developments
Table 89. Biotage Corporation Information
Table 90. Biotage Description and Major Businesses
Table 91. Biotage Product Models, Descriptions and Specifications
Table 92. Biotage Capacity, Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2020-2025)
Table 93. Biotage Sales Value Proportion by Product in 2024
Table 94. Biotage Sales Value Proportion by Application in 2024
Table 95. Biotage Sales Value Proportion by Geographic Area in 2024
Table 96. Biotage Peptide Synthesizer SWOT Analysis
Table 97. Biotage Recent Developments
Table 98. Shimadzu Corporation Information
Table 99. Shimadzu Description and Major Businesses
Table 100. Shimadzu Product Models, Descriptions and Specifications
Table 101. Shimadzu Capacity, Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2020-2025)
Table 102. Shimadzu Recent Developments
Table 103. Activotec Corporation Information
Table 104. Activotec Description and Major Businesses
Table 105. Activotec Product Models, Descriptions and Specifications
Table 106. Activotec Capacity, Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2020-2025)
Table 107. Activotec Recent Developments
Table 108. CS Bio Corporation Information
Table 109. CS Bio Description and Major Businesses
Table 110. CS Bio Product Models, Descriptions and Specifications
Table 111. CS Bio Capacity, Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2020-2025)
Table 112. CS Bio Recent Developments
Table 113. Intavis AG Corporation Information
Table 114. Intavis AG Description and Major Businesses
Table 115. Intavis AG Product Models, Descriptions and Specifications
Table 116. Intavis AG Capacity, Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2020-2025)
Table 117. Intavis AG Recent Developments
Table 118. Hainan JBPharm Corporation Information
Table 119. Hainan JBPharm Description and Major Businesses
Table 120. Hainan JBPharm Product Models, Descriptions and Specifications
Table 121. Hainan JBPharm Capacity, Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2020-2025)
Table 122. Hainan JBPharm Recent Developments
Table 123. Key Raw Materials Distribution
Table 124. Raw Materials Key Suppliers
Table 125. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 126. Milestones in Production Technology Evolution
Table 127. Distributors List
Table 128. Market Trends and Market Evolution
Table 129. Market Drivers and Opportunities
Table 130. Market Challenges, Risks, and Restraints
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
muLu

List of Figures

Figure 1. Peptide Synthesizer Product Picture
Figure 2. Global Peptide Synthesizer Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Mcg~mg Product Picture
Figure 4. Mg~g Product Picture
Figure 5. G~kg Product Picture
Figure 6. Above kg Product Picture
Figure 7. Global Peptide Synthesizer Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 8. University Laboratory
Figure 9. Biopharmaceutical Company
Figure 10. Synthesis Services Company
Figure 11. Peptide Synthesizer Report Years Considered
Figure 12. Global Peptide Synthesizer Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Peptide Synthesizer Revenue (2020-2031) & (US$ Million)
Figure 14. Global Peptide Synthesizer Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 15. Global Peptide Synthesizer Revenue Market Share by Region (2020-2031)
Figure 16. Global Peptide Synthesizer Sales (2020-2031) & (Units)
Figure 17. Global Peptide Synthesizer Sales (CAGR) by Region (2020-2031) (Units)
Figure 18. Global Peptide Synthesizer Sales Market Share by Region (2020-2031)
Figure 19. Global Peptide Synthesizer Capacity, Production and Utilization (2020-2031) & (Units)
Figure 20. Global Peptide Synthesizer Production Trend by Region (2020-2031) (Units)
Figure 21. Global Peptide Synthesizer Production Market Share by Region (2020-2031)
Figure 22. Production Capacity Enablers & Constraints
Figure 23. Peptide Synthesizer Production Growth Rate in North America (2020-2031) & (Units)
Figure 24. Peptide Synthesizer Production Growth Rate in Europe (2020-2031) & (Units)
Figure 25. Peptide Synthesizer Production Growth Rate in China (2020-2031) & (Units)
Figure 26. Peptide Synthesizer Production Growth Rate in Japan (2020-2031) & (Units)
Figure 27. Top 5 and Top 10 Manufacturers Peptide Synthesizer Sales Volume Market Share in 2024
Figure 28. Global Peptide Synthesizer Revenue Market Share Ranking (2024)
Figure 29. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 30. Mcg~mg Revenue Market Share by Manufacturer in 2024
Figure 31. Mg~g Revenue Market Share by Manufacturer in 2024
Figure 32. G~kg Revenue Market Share by Manufacturer in 2024
Figure 33. Above kg Revenue Market Share by Manufacturer in 2024
Figure 34. Type Eight Revenue Market Share by Manufacturer in 2024
Figure 35. Type Nine Revenue Market Share by Manufacturer in 2024
Figure 36. Global Peptide Synthesizer Sales Market Share by Type (2020-2031)
Figure 37. Global Peptide Synthesizer Revenue Market Share by Type (2020-2031)
Figure 38. Global Peptide Synthesizer Sales Market Share by Application (2020-2031)
Figure 39. Global Peptide Synthesizer Revenue Market Share by Application (2020-2031)
Figure 40. North America Peptide Synthesizer Sales YoY (2020-2031) & (Units)
Figure 41. North America Peptide Synthesizer Revenue YoY (2020-2031) & (US$ Million)
Figure 42. North America Top 5 Manufacturers Peptide Synthesizer Sales Revenue (US$ Million) in 2024
Figure 43. North America Peptide Synthesizer Sales Volume (Units) by Type (2020- 2031)
Figure 44. North America Peptide Synthesizer Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 45. North America Peptide Synthesizer Sales Volume (Units) by Application (2020-2031)
Figure 46. North America Peptide Synthesizer Sales Revenue (US$ Million) by Application (2020-2031)
Figure 47. US Peptide Synthesizer Revenue (2020-2031) & (US$ Million)
Figure 48. Canada Peptide Synthesizer Revenue (2020-2031) & (US$ Million)
Figure 49. Mexico Peptide Synthesizer Revenue (2020-2031) & (US$ Million)
Figure 50. Europe Peptide Synthesizer Sales YoY (2020-2031) & (Units)
Figure 51. Europe Peptide Synthesizer Revenue YoY (2020-2031) & (US$ Million)
Figure 52. Europe Top 5 Manufacturers Peptide Synthesizer Sales Revenue (US$ Million) in 2024
Figure 53. Europe Peptide Synthesizer Sales Volume (Units) by Type (2020-2031)
Figure 54. Europe Peptide Synthesizer Sales Revenue (US$ Million) by Type (2020-2031)
Figure 55. Europe Peptide Synthesizer Sales Volume (Units) by Application (2020-2031)
Figure 56. Europe Peptide Synthesizer Sales Revenue (US$ Million) by Application (2020-2031)
Figure 57. Germany Peptide Synthesizer Revenue (2020-2031) & (US$ Million)
Figure 58. France Peptide Synthesizer Revenue (2020-2031) & (US$ Million)
Figure 59. U.K. Peptide Synthesizer Revenue (2020-2031) & (US$ Million)
Figure 60. Italy Peptide Synthesizer Revenue (2020-2031) & (US$ Million)
Figure 61. Russia Peptide Synthesizer Revenue (2020-2031) & (US$ Million)
Figure 62. Asia-Pacific Peptide Synthesizer Sales YoY (2020-2031) & (Units)
Figure 63. Asia-Pacific Peptide Synthesizer Revenue YoY (2020-2031) & (US$ Million)
Figure 64. Asia-Pacific Top 8 Manufacturers Peptide Synthesizer Sales Revenue (US$ Million) in 2024
Figure 65. Asia-Pacific Peptide Synthesizer Sales Volume (Units) by Type (2020- 2031)
Figure 66. Asia-Pacific Peptide Synthesizer Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 67. Asia-Pacific Peptide Synthesizer Sales Volume (Units) by Application (2020-2031)
Figure 68. Asia-Pacific Peptide Synthesizer Sales Revenue (US$ Million) by Application (2020-2031)
Figure 69. Indonesia Peptide Synthesizer Revenue (2020-2031) & (US$ Million)
Figure 70. Japan Peptide Synthesizer Revenue (2020-2031) & (US$ Million)
Figure 71. South Korea Peptide Synthesizer Revenue (2020-2031) & (US$ Million)
Figure 72. China Taiwan Peptide Synthesizer Revenue (2020-2031) & (US$ Million)
Figure 73. India Peptide Synthesizer Revenue (2020-2031) & (US$ Million)
Figure 74. Central and South America Peptide Synthesizer Sales YoY (2020-2031) & (Units)
Figure 75. Central and South America Peptide Synthesizer Revenue YoY (2020-2031) & (US$ Million)
Figure 76. Central and South America Top 5 Manufacturers Peptide Synthesizer Sales Revenue (US$ Million) in 2024
Figure 77. Central and South America Peptide Synthesizer Sales Volume (Units) by Type (2021-2031)
Figure 78. Central and South America Peptide Synthesizer Sales Revenue (US$ Million) by Type (2020-2031)
Figure 79. Central and South America Peptide Synthesizer Sales Volume (Units) by Application (2020-2031)
Figure 80. Central and South America Peptide Synthesizer Sales Revenue (US$ Million) by Application (2020-2031)
Figure 81. Brazil Peptide Synthesizer Revenue (2020-2025) & (US$ Million)
Figure 82. Argentina Peptide Synthesizer Revenue (2020-2025) & (US$ Million)
Figure 83. Middle East, and Africa Peptide Synthesizer Sales YoY (2020-2031) & (Units)
Figure 84. Middle East and Africa Peptide Synthesizer Revenue YoY (2020-2031) & (US$ Million)
Figure 85. Middle East and Africa Top 5 Manufacturers Peptide Synthesizer Sales Revenue (US$ Million) in 2024
Figure 86. Middle East and Africa Peptide Synthesizer Sales Volume (Units) by Type (2021-2031)
Figure 87. South America Peptide Synthesizer Sales Revenue (US$ Million) by Type (2020-2031)
Figure 88. Middle East and Africa Peptide Synthesizer Sales Volume (Units) by Application (2020-2031)
Figure 89. Middle East and Africa Peptide Synthesizer Sales Revenue (US$ Million) by Application (2020-2031)
Figure 90. GCC Countries Peptide Synthesizer Revenue (2020-2025) & (US$ Million)
Figure 91. Turkey Peptide Synthesizer Revenue (2020-2025) & (US$ Million)
Figure 92. Egypt Peptide Synthesizer Revenue (2020-2025) & (US$ Million)
Figure 93. South Africa Peptide Synthesizer Revenue (2020-2025) & (US$ Million)
Figure 94. Peptide Synthesizer Industry Chain Mapping
Figure 95. Regional Peptide Synthesizer Manufacturing Base Distribution (%)
Figure 96. Peptide Synthesizer Production Process
Figure 97. Regional Peptide Synthesizer Production Cost Structure
Figure 98. Channels of Distribution (Direct Vs Distribution)
Figure 99. Bottom-up and Top-down Approaches for This Report
Figure 100. Data Triangulation
Figure 101. Key Executives Interviewed
den_biaoTiZhungShi

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Peptide Synthesizer market?zhanKai
The top companies in the global Peptide Synthesizer market are AAPPTec、PTI、PSI.
What was the global market size of Peptide Synthesizer in 2031?shouQi
What is the annual compound growth rate of the global Peptide Synthesizer market size from 2025 to 2031?shouQi
What was the global market size of Peptide Synthesizer in 2025?shouQi
Which region is expected to have the highest market share?shouQi
den_biaoTiZhungShi

Related Reports

Global Peptide Synthesizer Market Outlook, In‑Depth Analysis & Forecast to 2031

Industry: Machinery & Equipment

Published Date: 2025-09-11

Pages: 149 Pages

Report ld: 5043268

CHOOSE LICENSE TYPE
tip

USD 4900.00

tip

USD 7350.00

tip

USD 9800.00

Add to Cart

Add to Cart

Buy Now

Buy Now

HAVE A QUESTION?
SIMON LEE

English,Chinese

Offline

HITESH

English, Hindi

Offline

TANG XIN

Japanese,English

Offline

SUNG-BIN YOON

SUNG-BIN YOON

+82-2883 1278

Korean, English

Offline

YUJIE TIAN

Chinese, English

Offline

DAMON

Chinese, English

Offline

General Email:

REPORT COVERAGE

den_ic8

DESCRIPTION

zhankai
den_ic7

OVERVIEW

den_ic7

MARKET SEGMENTATION

den_ic7

CHAPTER OUTLINE

den_ic7

WHY THIS REPORT

den_ic7

QYRESEARCH'S STRENGTHS

den_ic8

TABLE OF CONTENTS

den_ic8

TABLE OF FIGURES

den_ic8

RLEATED REPORTS

INTEREST IN THIS REPORT?

yangBenGet A Free Sample

baoJia Request For Quotation

OR

NEED A CUSTOMIZED REPORT?

DingZhiCustomized Report

biaoTi

WORLD WIDE OFFICE

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

Add to Cart

Add to Cart

Buy Now

Buy Now